Katie Saxon is a strategic communications and public affairs specialist, with a decade of experience supporting healthcare clients in the UK, Europe and globally. She works with clients to create integrated communications strategies that differentiate and engage, with particular expertise in oncology and rare diseases. This support includes strategy and positioning, narrative and policy development, as well as capacity building, execution and issue management. Saxon has advised a host of life science companies on corporate, brand and market access initiatives, including Pfizer, Amgen, Novartis, Vertex and Biogen, as well as a variety of healthcare providers, NGOs and advocacy groups.
